The above results show that circ‐HACE1 is the candidate target for enhancing the COPD diagnostic accuracy; moreover, suppressing circ‐HACE1 may be beneficial for the treatment of COPD. The gene discussed is HACE1; the disease is chronic obstructive pulmonary disease.